Skip to main content
Erschienen in: Journal of Neuro-Oncology 3/2014

01.05.2014 | Topic Review

Epidemiology and etiopathogenesis of pituitary adenomas

verfasst von: Elena D. Aflorei, Márta Korbonits

Erschienen in: Journal of Neuro-Oncology | Ausgabe 3/2014

Einloggen, um Zugang zu erhalten

Abstract

Pituitary adenomas are usually benign monoclonal tumours presenting either due to hypersecretion of pituitary hormones, and/or due to local space occupying effects and hyposecretion of some or all of the pituitary hormones. Some pituitary adenomas cause prominent symptoms, while others may result in slowly developing, insidious, non-specific complains delaying accurate diagnosis, with a third group remaining symptomless and recognised only incidentally. Therefore, it is a challenge to accurately determine the prevalence and incidence of pituitary adenomas in the general population. The vast majority of pituitary adenomas occur sporadically, but familial cases are now increasingly recognised. Hereditary predisposition, somatic mutations and endocrine factors were shown to have a pathophysiologic role in the initiation and progression of pituitary adenomas, which interestingly almost always remain benign. Here, we summarize the available epidemiological data and the known pathogenesis of the pituitary adenomas.
Literatur
1.
2.
Zurück zum Zitat Nilsson B, Gustavasson-Kadaka E, Bengtsson BA, Jonsson B (2000) Pituitary adenomas in Sweden between 1958 and 1991: incidence, survival, and mortality. J Clin Endocrinol Metab 85(4):1420–1425. doi:10.1210/jc.85.4.1420 PubMed Nilsson B, Gustavasson-Kadaka E, Bengtsson BA, Jonsson B (2000) Pituitary adenomas in Sweden between 1958 and 1991: incidence, survival, and mortality. J Clin Endocrinol Metab 85(4):1420–1425. doi:10.​1210/​jc.​85.​4.​1420 PubMed
3.
4.
Zurück zum Zitat Shibui S (2012) The present status and trend of brain tumors based on the data of the Brain Tumor Registry of Japan. Brain Nerve 64(3):286–290PubMed Shibui S (2012) The present status and trend of brain tumors based on the data of the Brain Tumor Registry of Japan. Brain Nerve 64(3):286–290PubMed
8.
Zurück zum Zitat Chambers EF, Turski PA, LaMasters D, Newton TH (1982) Regions of low density in the contrast-enhanced pituitary gland: normal and pathologic processes. Radiology 144(1):109–113PubMed Chambers EF, Turski PA, LaMasters D, Newton TH (1982) Regions of low density in the contrast-enhanced pituitary gland: normal and pathologic processes. Radiology 144(1):109–113PubMed
9.
Zurück zum Zitat Ezzat S, Asa SL, Couldwell WT, Barr CE, Dodge WE, Vance ML, McCutcheon IE (2004) The prevalence of pituitary adenomas: a systematic review. Cancer 101(3):613–619. doi:10.1002/cncr.20412 PubMed Ezzat S, Asa SL, Couldwell WT, Barr CE, Dodge WE, Vance ML, McCutcheon IE (2004) The prevalence of pituitary adenomas: a systematic review. Cancer 101(3):613–619. doi:10.​1002/​cncr.​20412 PubMed
10.
Zurück zum Zitat Nammour GM, Ybarra J, Naheedy MH, Romeo JH, Aron DC (1997) Incidental pituitary macroadenoma: a population-based study. Am J Med Sci 314(5):287–291PubMed Nammour GM, Ybarra J, Naheedy MH, Romeo JH, Aron DC (1997) Incidental pituitary macroadenoma: a population-based study. Am J Med Sci 314(5):287–291PubMed
11.
Zurück zum Zitat Yue NC, Longstreth WT Jr, Elster AD, Jungreis CA, O’Leary DH, Poirier VC (1997) Clinically serious abnormalities found incidentally at MR imaging of the brain: data from the Cardiovascular Health Study. Radiology 202(1):41–46PubMed Yue NC, Longstreth WT Jr, Elster AD, Jungreis CA, O’Leary DH, Poirier VC (1997) Clinically serious abnormalities found incidentally at MR imaging of the brain: data from the Cardiovascular Health Study. Radiology 202(1):41–46PubMed
12.
Zurück zum Zitat Hartwigsen G, Siebner HR, Deuschl G, Jansen O, Ulmer S (2010) Incidental findings are frequent in young healthy individuals undergoing magnetic resonance imaging in brain research imaging studies: a prospective single-center study. J Comput Assist Tomogr 34(4):596–600. doi:10.1097/RCT.0b013e3181d9c2bb PubMed Hartwigsen G, Siebner HR, Deuschl G, Jansen O, Ulmer S (2010) Incidental findings are frequent in young healthy individuals undergoing magnetic resonance imaging in brain research imaging studies: a prospective single-center study. J Comput Assist Tomogr 34(4):596–600. doi:10.​1097/​RCT.​0b013e3181d9c2bb​ PubMed
13.
Zurück zum Zitat Vernooij MW, Ikram MA, Tanghe HL, Vincent AJ, Hofman A, Krestin GP, Niessen WJ, Breteler MM, van der Lugt A (2007) Incidental findings on brain MRI in the general population. N Engl J Med 357(18):1821–1828. doi:10.1056/NEJMoa070972 PubMed Vernooij MW, Ikram MA, Tanghe HL, Vincent AJ, Hofman A, Krestin GP, Niessen WJ, Breteler MM, van der Lugt A (2007) Incidental findings on brain MRI in the general population. N Engl J Med 357(18):1821–1828. doi:10.​1056/​NEJMoa070972 PubMed
14.
Zurück zum Zitat Freda PU, Beckers AM, Katznelson L, Molitch ME, Montori VM, Post KD, Vance ML (2011) Pituitary incidentaloma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 96(4):894–904. doi:10.1210/jc.2010-1048 PubMed Freda PU, Beckers AM, Katznelson L, Molitch ME, Montori VM, Post KD, Vance ML (2011) Pituitary incidentaloma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 96(4):894–904. doi:10.​1210/​jc.​2010-1048 PubMed
15.
Zurück zum Zitat Clayton RN (1999) Sporadic pituitary tumours: from epidemiology to use of databases. Baillieres Best Pract Res Clin Endocrinol Metab 13(3):451–460PubMed Clayton RN (1999) Sporadic pituitary tumours: from epidemiology to use of databases. Baillieres Best Pract Res Clin Endocrinol Metab 13(3):451–460PubMed
16.
Zurück zum Zitat Ambrosi B, Faglia G (1991) Epidemiology of pituitary tumors. In: Faglia G, Ambrosi B, Travalini P, Spada A, Beck-Peccoz P (eds) Pituitary adenomas: new trends in basic and clinical research. Elsevier Science, Amsterdam, pp 159–168 Ambrosi B, Faglia G (1991) Epidemiology of pituitary tumors. In: Faglia G, Ambrosi B, Travalini P, Spada A, Beck-Peccoz P (eds) Pituitary adenomas: new trends in basic and clinical research. Elsevier Science, Amsterdam, pp 159–168
17.
Zurück zum Zitat Daly AF, Rixhon M, Adam C, Dempegioti A, Tichomirowa MA, Beckers A (2006) High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium. J Clin Endocr Metab 91(12):4769–4775. doi:10.1210/jc.2006-1668 PubMed Daly AF, Rixhon M, Adam C, Dempegioti A, Tichomirowa MA, Beckers A (2006) High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium. J Clin Endocr Metab 91(12):4769–4775. doi:10.​1210/​jc.​2006-1668 PubMed
18.
Zurück zum Zitat Fontana E, Gaillard R (2009) Epidemiology of pituitary adenoma: results of the first Swiss study. Rev Med Suisse 5(223):2172–2174PubMed Fontana E, Gaillard R (2009) Epidemiology of pituitary adenoma: results of the first Swiss study. Rev Med Suisse 5(223):2172–2174PubMed
19.
Zurück zum Zitat Fernandez A, Karavitaki N, Wass JA (2010) Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK). Clin Endocrinol (Oxf) 72(3):377–382. doi:10.1016/j.ccr.2006.04.024 Fernandez A, Karavitaki N, Wass JA (2010) Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK). Clin Endocrinol (Oxf) 72(3):377–382. doi:10.​1016/​j.​ccr.​2006.​04.​024
20.
Zurück zum Zitat Raappana A, Koivukangas J, Ebeling T, Pirila T (2010) Incidence of pituitary adenomas in Northern Finland in 1992–2007. J Clin Endocrinol Metab 95(9):4268–4275. doi:10.1210/jc.2010-0537 PubMed Raappana A, Koivukangas J, Ebeling T, Pirila T (2010) Incidence of pituitary adenomas in Northern Finland in 1992–2007. J Clin Endocrinol Metab 95(9):4268–4275. doi:10.​1210/​jc.​2010-0537 PubMed
21.
22.
Zurück zum Zitat Daly AF, Cogne M, Tabarin A, Murat A, Delemer B, Luger A, Gaillard R, Colao A, Harris AG, Herlocu MC, Petrossians P, Beckers A (2007) The epidemiology of pituitary tumors: Results of an international collaborative study. In: The endocrine society annual meeting 2007, Toronto, Canada Daly AF, Cogne M, Tabarin A, Murat A, Delemer B, Luger A, Gaillard R, Colao A, Harris AG, Herlocu MC, Petrossians P, Beckers A (2007) The epidemiology of pituitary tumors: Results of an international collaborative study. In: The endocrine society annual meeting 2007, Toronto, Canada
23.
Zurück zum Zitat Schneider HJ, Sievers C, Saller B, Wittchen HU, Stalla GK (2008) High prevalence of biochemical acromegaly in primary care patients with elevated IGF-1 levels. Clin Endocrinol (Oxf) 69(3):432–435. doi:10.1111/j.1365-2265.2008.03221.x Schneider HJ, Sievers C, Saller B, Wittchen HU, Stalla GK (2008) High prevalence of biochemical acromegaly in primary care patients with elevated IGF-1 levels. Clin Endocrinol (Oxf) 69(3):432–435. doi:10.​1111/​j.​1365-2265.​2008.​03221.​x
24.
Zurück zum Zitat Gold EB (1981) Epidemiology of pituitary adenomas. Epidemiol Rev 3:163–183PubMed Gold EB (1981) Epidemiology of pituitary adenomas. Epidemiol Rev 3:163–183PubMed
27.
Zurück zum Zitat Teramoto A, Hirakawa K, Sanno N, Osamura Y (1994) Incidental pituitary lesions in 1,000 unselected autopsy specimens. Radiology 193(1):161–164PubMed Teramoto A, Hirakawa K, Sanno N, Osamura Y (1994) Incidental pituitary lesions in 1,000 unselected autopsy specimens. Radiology 193(1):161–164PubMed
28.
Zurück zum Zitat Heshmat MY, Kovi J, Simpson C, Kennedy J, Fan KJ (1976) Neoplasms of the central nervous system: incidence and population selectivity in the Washington DC, metropolitan area. Cancer 38(5):2135–2142PubMed Heshmat MY, Kovi J, Simpson C, Kennedy J, Fan KJ (1976) Neoplasms of the central nervous system: incidence and population selectivity in the Washington DC, metropolitan area. Cancer 38(5):2135–2142PubMed
30.
31.
Zurück zum Zitat Meij BP, Lopes MB, Ellegala DB, Alden TD, Laws ER Jr (2002) The long-term significance of microscopic dural invasion in 354 patients with pituitary adenomas treated with transsphenoidal surgery. J Neurosurg 96(2):195–208. doi:10.3171/jns.2002.96.2.0195 PubMed Meij BP, Lopes MB, Ellegala DB, Alden TD, Laws ER Jr (2002) The long-term significance of microscopic dural invasion in 354 patients with pituitary adenomas treated with transsphenoidal surgery. J Neurosurg 96(2):195–208. doi:10.​3171/​jns.​2002.​96.​2.​0195 PubMed
32.
Zurück zum Zitat Ragel BT, Couldwell WT (2004) Pituitary carcinoma: a review of the literature. Neurosurg Focus 16(4):E7PubMed Ragel BT, Couldwell WT (2004) Pituitary carcinoma: a review of the literature. Neurosurg Focus 16(4):E7PubMed
33.
Zurück zum Zitat Mixson AJ, Friedman TC, Katz DA, Feuerstein IM, Taubenberger JK, Colandrea JM, Doppman JL, Oldfield EH, Weintraub BD (1993) Thyrotropin-secreting pituitary carcinoma. J Clin Endocrinol Metab 76(2):529–533. doi:10.1210/jc.76.2.529 PubMed Mixson AJ, Friedman TC, Katz DA, Feuerstein IM, Taubenberger JK, Colandrea JM, Doppman JL, Oldfield EH, Weintraub BD (1993) Thyrotropin-secreting pituitary carcinoma. J Clin Endocrinol Metab 76(2):529–533. doi:10.​1210/​jc.​76.​2.​529 PubMed
36.
Zurück zum Zitat Morokuma H, Ando T, Hayashida T, Horie I, Inoshita N, Murata F, Ueki I, Nakamura K, Imaizumi M, Usa T, Kawakami A (2012) A case of nonfunctioning pituitary carcinoma that responded to temozolomide treatment. Case Rep Endocrinol 2012:645914. doi:10.1155/2012/645914 PubMedCentralPubMed Morokuma H, Ando T, Hayashida T, Horie I, Inoshita N, Murata F, Ueki I, Nakamura K, Imaizumi M, Usa T, Kawakami A (2012) A case of nonfunctioning pituitary carcinoma that responded to temozolomide treatment. Case Rep Endocrinol 2012:645914. doi:10.​1155/​2012/​645914 PubMedCentralPubMed
37.
Zurück zum Zitat Kovacs GL, Goth M, Rotondo F, Scheithauer BW, Carlsen E, Saadia A, Hubina E, Kovacs L, Szabolcs I, Nagy P, Czirjak S, Hanzely Z, Kovacs K, Horvath E, Korbonits M (2013) ACTH-secreting Crooke cell carcinoma of the pituitary. Eur J Clin Invest 43(1):20–26. doi:10.1111/eci.12010 PubMed Kovacs GL, Goth M, Rotondo F, Scheithauer BW, Carlsen E, Saadia A, Hubina E, Kovacs L, Szabolcs I, Nagy P, Czirjak S, Hanzely Z, Kovacs K, Horvath E, Korbonits M (2013) ACTH-secreting Crooke cell carcinoma of the pituitary. Eur J Clin Invest 43(1):20–26. doi:10.​1111/​eci.​12010 PubMed
38.
Zurück zum Zitat Kaltsas GA, Nomikos P, Kontogeorgos G, Buchfelder M, Grossman AB (2005) Clinical review: diagnosis and management of pituitary carcinomas. J Clin Endocrinol Metab 90(5):3089–3099. doi:10.1210/jc.2004-2231 PubMed Kaltsas GA, Nomikos P, Kontogeorgos G, Buchfelder M, Grossman AB (2005) Clinical review: diagnosis and management of pituitary carcinomas. J Clin Endocrinol Metab 90(5):3089–3099. doi:10.​1210/​jc.​2004-2231 PubMed
40.
41.
Zurück zum Zitat Raverot G, Wierinckx A, Dantony E, Auger C, Chapas G, Villeneuve L, Brue T, Figarella-Branger D, Roy P, Jouanneau E, Jan M, Lachuer J, Trouillas J (2010) Prognostic factors in prolactin pituitary tumors: clinical, histological, and molecular data from a series of 94 patients with a long postoperative follow-up. J Clin Endocrinol Metab 95(4):1708–1716. doi:10.1210/jc.2009-1191 PubMed Raverot G, Wierinckx A, Dantony E, Auger C, Chapas G, Villeneuve L, Brue T, Figarella-Branger D, Roy P, Jouanneau E, Jan M, Lachuer J, Trouillas J (2010) Prognostic factors in prolactin pituitary tumors: clinical, histological, and molecular data from a series of 94 patients with a long postoperative follow-up. J Clin Endocrinol Metab 95(4):1708–1716. doi:10.​1210/​jc.​2009-1191 PubMed
42.
Zurück zum Zitat Wierinckx A, Auger C, Devauchelle P, Reynaud A, Chevallier P, Jan M, Perrin G, Fevre-Montange M, Rey C, Figarella-Branger D, Raverot G, Belin MF, Lachuer J, Trouillas J (2007) A diagnostic marker set for invasion, proliferation, and aggressiveness of prolactin pituitary tumors. Endocr Relat Cancer 14(3):887–900. doi:10.1677/ERC-07-0062 PubMed Wierinckx A, Auger C, Devauchelle P, Reynaud A, Chevallier P, Jan M, Perrin G, Fevre-Montange M, Rey C, Figarella-Branger D, Raverot G, Belin MF, Lachuer J, Trouillas J (2007) A diagnostic marker set for invasion, proliferation, and aggressiveness of prolactin pituitary tumors. Endocr Relat Cancer 14(3):887–900. doi:10.​1677/​ERC-07-0062 PubMed
43.
Zurück zum Zitat Galland F, Lacroix L, Saulnier P, Dessen P, Meduri G, Bernier M, Gaillard S, Guibourdenche J, Fournier T, Evain-Brion D, Bidart JM, Chanson P (2010) Differential gene expression profiles of invasive and non-invasive non-functioning pituitary adenomas based on microarray analysis. Endocr Relat Cancer 17(2):361–371. doi:10.1677/ERC-10-0018 PubMed Galland F, Lacroix L, Saulnier P, Dessen P, Meduri G, Bernier M, Gaillard S, Guibourdenche J, Fournier T, Evain-Brion D, Bidart JM, Chanson P (2010) Differential gene expression profiles of invasive and non-invasive non-functioning pituitary adenomas based on microarray analysis. Endocr Relat Cancer 17(2):361–371. doi:10.​1677/​ERC-10-0018 PubMed
44.
Zurück zum Zitat Potter VR (1980) Initiation and promotion in cancer formation: the importance of studies on intercellular communication. Yale J Biol Med 53(5):367–384PubMedCentralPubMed Potter VR (1980) Initiation and promotion in cancer formation: the importance of studies on intercellular communication. Yale J Biol Med 53(5):367–384PubMedCentralPubMed
46.
Zurück zum Zitat Clayton RN, Pfeifer M, Atkinson AB, Belchetz P, Wass JA, Kyrodimou E, Vanderpump M, Simpson D, Bicknell J, Farrell WE (2000) Different patterns of allelic loss (loss of heterozygosity) in recurrent human pituitary tumors provide evidence for multiclonal origins. Clin Cancer Res 6(10):3973–3982PubMed Clayton RN, Pfeifer M, Atkinson AB, Belchetz P, Wass JA, Kyrodimou E, Vanderpump M, Simpson D, Bicknell J, Farrell WE (2000) Different patterns of allelic loss (loss of heterozygosity) in recurrent human pituitary tumors provide evidence for multiclonal origins. Clin Cancer Res 6(10):3973–3982PubMed
47.
Zurück zum Zitat McAndrew J, Paterson AJ, Asa SL, McCarthy KJ, Kudlow JE (1995) Targeting of transforming growth factor-alpha expression to pituitary lactotrophs in transgenic mice results in selective lactotroph proliferation and adenomas. Endocrinology 136(10):4479–4488. doi:10.1210/en.136.10.4479 PubMed McAndrew J, Paterson AJ, Asa SL, McCarthy KJ, Kudlow JE (1995) Targeting of transforming growth factor-alpha expression to pituitary lactotrophs in transgenic mice results in selective lactotroph proliferation and adenomas. Endocrinology 136(10):4479–4488. doi:10.​1210/​en.​136.​10.​4479 PubMed
48.
Zurück zum Zitat Pellegrini I, Barlier A, Gunz G, Figarella-Branger D, Enjalbert A, Grisoli F, Jaquet P (1994) Pit-1 gene expression in the human pituitary and pituitary adenomas. J Clin Endocrinol Metab 79(1):189–196. doi:10.1210/jc.79.1.189 PubMed Pellegrini I, Barlier A, Gunz G, Figarella-Branger D, Enjalbert A, Grisoli F, Jaquet P (1994) Pit-1 gene expression in the human pituitary and pituitary adenomas. J Clin Endocrinol Metab 79(1):189–196. doi:10.​1210/​jc.​79.​1.​189 PubMed
49.
Zurück zum Zitat Riss D, Jin L, Qian X, Bayliss J, Scheithauer BW, Young WF Jr, Vidal S, Kovacs K, Raz A, Lloyd RV (2003) Differential expression of galectin-3 in pituitary tumors. Cancer Res 63(9):2251–2255PubMed Riss D, Jin L, Qian X, Bayliss J, Scheithauer BW, Young WF Jr, Vidal S, Kovacs K, Raz A, Lloyd RV (2003) Differential expression of galectin-3 in pituitary tumors. Cancer Res 63(9):2251–2255PubMed
50.
Zurück zum Zitat Takino H, Herman V, Weiss M, Melmed S (1995) Purine-binding factor (nm23) gene expression in pituitary tumors: marker of adenoma invasiveness. J Clin Endocrinol Metab 80(5):1733–1738. doi:10.1210/jc.80.5.1733 PubMed Takino H, Herman V, Weiss M, Melmed S (1995) Purine-binding factor (nm23) gene expression in pituitary tumors: marker of adenoma invasiveness. J Clin Endocrinol Metab 80(5):1733–1738. doi:10.​1210/​jc.​80.​5.​1733 PubMed
51.
55.
Zurück zum Zitat Cai WY, Alexander JM, Hedley-Whyte ET, Scheithauer BW, Jameson JL, Zervas NT, Klibanski A (1994) ras mutations in human prolactinomas and pituitary carcinomas. J Clin Endocr Metab 78(1):89–93. doi:10.1210/jc.78.1.89 PubMed Cai WY, Alexander JM, Hedley-Whyte ET, Scheithauer BW, Jameson JL, Zervas NT, Klibanski A (1994) ras mutations in human prolactinomas and pituitary carcinomas. J Clin Endocr Metab 78(1):89–93. doi:10.​1210/​jc.​78.​1.​89 PubMed
56.
57.
Zurück zum Zitat Knudson AG Jr (1971) Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 68(4):820–823PubMedCentralPubMed Knudson AG Jr (1971) Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 68(4):820–823PubMedCentralPubMed
58.
60.
Zurück zum Zitat Zhang X, Sun H, Danila DC, Johnson SR, Zhou Y, Swearingen B, Klibanski A (2002) Loss of expression of GADD45 gamma, a growth inhibitory gene, in human pituitary adenomas: implications for tumorigenesis. J Clin Endocrinol Metab 87(3):1262–1267. doi:10.1210/jc.87.3.1262 PubMed Zhang X, Sun H, Danila DC, Johnson SR, Zhou Y, Swearingen B, Klibanski A (2002) Loss of expression of GADD45 gamma, a growth inhibitory gene, in human pituitary adenomas: implications for tumorigenesis. J Clin Endocrinol Metab 87(3):1262–1267. doi:10.​1210/​jc.​87.​3.​1262 PubMed
61.
Zurück zum Zitat Zhang X, Rice K, Wang Y, Chen W, Zhong Y, Nakayama Y, Zhou Y, Klibanski A (2010) Maternally expressed gene 3 (MEG3) noncoding ribonucleic acid: isoform structure, expression, and functions. Endocrinology 151(3):939–947. doi:10.1210/en.2009-0657 PubMedCentralPubMed Zhang X, Rice K, Wang Y, Chen W, Zhong Y, Nakayama Y, Zhou Y, Klibanski A (2010) Maternally expressed gene 3 (MEG3) noncoding ribonucleic acid: isoform structure, expression, and functions. Endocrinology 151(3):939–947. doi:10.​1210/​en.​2009-0657 PubMedCentralPubMed
62.
Zurück zum Zitat Wierinckx A, Roche M, Raverot G, Legras-Lachuer C, Croze S, Nazaret N, Rey C, Auger C, Jouanneau E, Chanson P, Trouillas J, Lachuer J (2011) Integrated genomic profiling identifies loss of chromosome 11p impacting transcriptomic activity in aggressive pituitary PRL tumors. Brain Pathol 21(5):533–543. doi:10.1111/j.1750-3639.2011.00476.x PubMed Wierinckx A, Roche M, Raverot G, Legras-Lachuer C, Croze S, Nazaret N, Rey C, Auger C, Jouanneau E, Chanson P, Trouillas J, Lachuer J (2011) Integrated genomic profiling identifies loss of chromosome 11p impacting transcriptomic activity in aggressive pituitary PRL tumors. Brain Pathol 21(5):533–543. doi:10.​1111/​j.​1750-3639.​2011.​00476.​x PubMed
63.
Zurück zum Zitat Jacks T, Fazeli A, Schmitt EM, Bronson RT, Goodell MA, Weinberg RA (1992) Effects of an Rb mutation in the mouse. Nature 359(6393):295–300. doi:10.1038/359295a0 PubMed Jacks T, Fazeli A, Schmitt EM, Bronson RT, Goodell MA, Weinberg RA (1992) Effects of an Rb mutation in the mouse. Nature 359(6393):295–300. doi:10.​1038/​359295a0 PubMed
64.
Zurück zum Zitat Kiyokawa H, Kineman RD, Manova-Todorova KO, Soares VC, Hoffman ES, Ono M, Khanam D, Hayday AC, Frohman LA, Koff A (1996) Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1). Cell 85(5):721–732PubMed Kiyokawa H, Kineman RD, Manova-Todorova KO, Soares VC, Hoffman ES, Ono M, Khanam D, Hayday AC, Frohman LA, Koff A (1996) Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1). Cell 85(5):721–732PubMed
65.
Zurück zum Zitat Moreno CS, Evans CO, Zhan X, Okor M, Desiderio DM, Oyesiku NM (2005) Novel molecular signaling and classification of human clinically nonfunctional pituitary adenomas identified by gene expression profiling and proteomic analyses. Cancer Res 65(22):10214–10222. doi:10.1158/0008-5472.CAN-05-0884 PubMed Moreno CS, Evans CO, Zhan X, Okor M, Desiderio DM, Oyesiku NM (2005) Novel molecular signaling and classification of human clinically nonfunctional pituitary adenomas identified by gene expression profiling and proteomic analyses. Cancer Res 65(22):10214–10222. doi:10.​1158/​0008-5472.​CAN-05-0884 PubMed
66.
Zurück zum Zitat Jordan S, Lidhar K, Korbonits M, Lowe DG, Grossman AB (2000) Cyclin D and cyclin E expression in normal and adenomatous pituitary. Eur J Endocrinol 143(1):R1–R6. doi:10.1530/eje.0.143R001 PubMed Jordan S, Lidhar K, Korbonits M, Lowe DG, Grossman AB (2000) Cyclin D and cyclin E expression in normal and adenomatous pituitary. Eur J Endocrinol 143(1):R1–R6. doi:10.​1530/​eje.​0.​143R001 PubMed
68.
Zurück zum Zitat Kirsch M, Morz M, Pinzer T, Schackert HK, Schackert G (2009) Frequent loss of the CDKN2C (p18INK4c) gene product in pituitary adenomas. Genes Chromosom Cancer 48(2):143–154. doi:10.1002/gcc.20621 PubMed Kirsch M, Morz M, Pinzer T, Schackert HK, Schackert G (2009) Frequent loss of the CDKN2C (p18INK4c) gene product in pituitary adenomas. Genes Chromosom Cancer 48(2):143–154. doi:10.​1002/​gcc.​20621 PubMed
69.
Zurück zum Zitat Franklin DS, Godfrey VL, Lee H, Kovalev GI, Schoonhoven R, Chen-Kiang S, Su L, Xiong Y (1998) CDK inhibitors p18(INK4c) and p27(Kip1) mediate two separate pathways to collaboratively suppress pituitary tumorigenesis. Genes Dev 12(18):2899–2911. doi:10.1101/gad.12.18.2899 PubMedCentralPubMed Franklin DS, Godfrey VL, Lee H, Kovalev GI, Schoonhoven R, Chen-Kiang S, Su L, Xiong Y (1998) CDK inhibitors p18(INK4c) and p27(Kip1) mediate two separate pathways to collaboratively suppress pituitary tumorigenesis. Genes Dev 12(18):2899–2911. doi:10.​1101/​gad.​12.​18.​2899 PubMedCentralPubMed
71.
Zurück zum Zitat Hunter JA, Skelly RH, Aylwin SJ, Geddes JF, Evanson J, Besser GM, Monson JP, Burrin JM (2003) The relationship between pituitary tumour transforming gene (PTTG) expression and in vitro hormone and vascular endothelial growth factor (VEGF) secretion from human pituitary adenomas. Eur J Endocrinol 148(2):203–211. doi:10.1530/eje.0.1480203 PubMed Hunter JA, Skelly RH, Aylwin SJ, Geddes JF, Evanson J, Besser GM, Monson JP, Burrin JM (2003) The relationship between pituitary tumour transforming gene (PTTG) expression and in vitro hormone and vascular endothelial growth factor (VEGF) secretion from human pituitary adenomas. Eur J Endocrinol 148(2):203–211. doi:10.​1530/​eje.​0.​1480203 PubMed
72.
Zurück zum Zitat Filippella M, Galland F, Kujas M, Young J, Faggiano A, Lombardi G, Colao A, Meduri G, Chanson P (2006) Pituitary tumour transforming gene (PTTG) expression correlates with the proliferative activity and recurrence status of pituitary adenomas: a clinical and immunohistochemical study. Clin Endocrinol (Oxf) 65(4):536–543. doi:10.1111/j.1365-2265.2006.02630.x Filippella M, Galland F, Kujas M, Young J, Faggiano A, Lombardi G, Colao A, Meduri G, Chanson P (2006) Pituitary tumour transforming gene (PTTG) expression correlates with the proliferative activity and recurrence status of pituitary adenomas: a clinical and immunohistochemical study. Clin Endocrinol (Oxf) 65(4):536–543. doi:10.​1111/​j.​1365-2265.​2006.​02630.​x
74.
Zurück zum Zitat Zhang X, Horwitz GA, Heaney AP, Nakashima M, Prezant TR, Bronstein MD, Melmed S (1999) Pituitary tumor transforming gene (PTTG) expression in pituitary adenomas. J Clin Endocrinol Metab 84(2):761–767. doi:10.1210/jc.84.2.761 PubMed Zhang X, Horwitz GA, Heaney AP, Nakashima M, Prezant TR, Bronstein MD, Melmed S (1999) Pituitary tumor transforming gene (PTTG) expression in pituitary adenomas. J Clin Endocrinol Metab 84(2):761–767. doi:10.​1210/​jc.​84.​2.​761 PubMed
75.
Zurück zum Zitat Bazina M, Vukojevic K, Roje D, Saraga-Babic M (2009) Influence of growth and transcriptional factors, and signaling molecules on early human pituitary development. J Mol Histol 40(4):277–286. doi:10.1007/s10735-009-9239-9 PubMed Bazina M, Vukojevic K, Roje D, Saraga-Babic M (2009) Influence of growth and transcriptional factors, and signaling molecules on early human pituitary development. J Mol Histol 40(4):277–286. doi:10.​1007/​s10735-009-9239-9 PubMed
76.
Zurück zum Zitat Ezzat S, Zheng L, Zhu XF, Wu GE, Asa SL (2002) Targeted expression of a human pituitary tumor-derived isoform of FGF receptor-4 recapitulates pituitary tumorigenesis. J Clin Invest 109(1):69–78. doi:10.1172/JCI14036 PubMedCentralPubMed Ezzat S, Zheng L, Zhu XF, Wu GE, Asa SL (2002) Targeted expression of a human pituitary tumor-derived isoform of FGF receptor-4 recapitulates pituitary tumorigenesis. J Clin Invest 109(1):69–78. doi:10.​1172/​JCI14036 PubMedCentralPubMed
77.
Zurück zum Zitat Theodoropoulou M, Arzberger T, Gruebler Y, Jaffrain-Rea ML, Schlegel J, Schaaf L, Petrangeli E, Losa M, Stalla GK, Pagotto U (2004) Expression of epidermal growth factor receptor in neoplastic pituitary cells: evidence for a role in corticotropinoma cells. J Endocrinol 183(2):385–394. doi:10.1677/joe.1.05616 PubMed Theodoropoulou M, Arzberger T, Gruebler Y, Jaffrain-Rea ML, Schlegel J, Schaaf L, Petrangeli E, Losa M, Stalla GK, Pagotto U (2004) Expression of epidermal growth factor receptor in neoplastic pituitary cells: evidence for a role in corticotropinoma cells. J Endocrinol 183(2):385–394. doi:10.​1677/​joe.​1.​05616 PubMed
78.
Zurück zum Zitat Missale C, Boroni F, Losa M, Giovanelli M, Zanellato A, Dal TR, Balsari A, Spano P (1993) Nerve growth factor suppresses the transforming phenotype of human prolactinomas. Proc Natl Acad Sci USA 90(17):7961–7965PubMedCentralPubMed Missale C, Boroni F, Losa M, Giovanelli M, Zanellato A, Dal TR, Balsari A, Spano P (1993) Nerve growth factor suppresses the transforming phenotype of human prolactinomas. Proc Natl Acad Sci USA 90(17):7961–7965PubMedCentralPubMed
79.
Zurück zum Zitat Shorts-Cary L, Xu M, Ertel J, Kleinschmidt-Demasters BK, Lillehei K, Matsuoka I, Nielsen-Preiss S, Wierman ME (2007) Bone morphogenetic protein and retinoic acid-inducible neural specific protein-3 is expressed in gonadotrope cell pituitary adenomas and induces proliferation, migration, and invasion. Endocrinology 148(3):967–975. doi:10.1210/en.2006-0905 PubMed Shorts-Cary L, Xu M, Ertel J, Kleinschmidt-Demasters BK, Lillehei K, Matsuoka I, Nielsen-Preiss S, Wierman ME (2007) Bone morphogenetic protein and retinoic acid-inducible neural specific protein-3 is expressed in gonadotrope cell pituitary adenomas and induces proliferation, migration, and invasion. Endocrinology 148(3):967–975. doi:10.​1210/​en.​2006-0905 PubMed
80.
Zurück zum Zitat Fedele M, Visone R, De Martino I, Troncone G, Palmieri D, Battista S, Ciarmiello A, Pallante P, Arra C, Melillo RM, Helin K, Croce CM, Fusco A (2006) HMGA2 induces pituitary tumorigenesis by enhancing E2F1 activity. Cancer Cell 9(6):459–471. doi:10.1016/j.ccr.2006.04.024 PubMed Fedele M, Visone R, De Martino I, Troncone G, Palmieri D, Battista S, Ciarmiello A, Pallante P, Arra C, Melillo RM, Helin K, Croce CM, Fusco A (2006) HMGA2 induces pituitary tumorigenesis by enhancing E2F1 activity. Cancer Cell 9(6):459–471. doi:10.​1016/​j.​ccr.​2006.​04.​024 PubMed
81.
Zurück zum Zitat Ahtiainen P, Sharp V, Rulli SB, Rivero-Muller A, Mamaeva V, Roytta M, Huhtaniemi I (2010) Enhanced LH action in transgenic female mice expressing hCGbeta-subunit induces pituitary prolactinomas; the role of high progesterone levels. Endocr-Relat Cancer 17(3):611–621. doi:10.1677/ERC-10-0016 PubMedCentralPubMed Ahtiainen P, Sharp V, Rulli SB, Rivero-Muller A, Mamaeva V, Roytta M, Huhtaniemi I (2010) Enhanced LH action in transgenic female mice expressing hCGbeta-subunit induces pituitary prolactinomas; the role of high progesterone levels. Endocr-Relat Cancer 17(3):611–621. doi:10.​1677/​ERC-10-0016 PubMedCentralPubMed
82.
Zurück zum Zitat Palmieri D, Valentino T, De Matino I, Esposito F, Cappabianca P, Wierinckx A, Vitiello M, Lombardi G, Colao A, Trouillas J, Pierantoni GM, Fusco A, Fedele M (2012) PIT1 upregulation by HMGA proteins has a role in pituitary tumorigenesis. Endocr Relat Cancer 19(2):123–135. doi:10.1530/ERC-11-0135 PubMed Palmieri D, Valentino T, De Matino I, Esposito F, Cappabianca P, Wierinckx A, Vitiello M, Lombardi G, Colao A, Trouillas J, Pierantoni GM, Fusco A, Fedele M (2012) PIT1 upregulation by HMGA proteins has a role in pituitary tumorigenesis. Endocr Relat Cancer 19(2):123–135. doi:10.​1530/​ERC-11-0135 PubMed
85.
Zurück zum Zitat Trivellin G, Butz H, Delhove J, Igreja S, Chahal HS, Zivkovic V, McKay T, Patocs A, Grossman AB, Korbonits M (2012) MicroRNA miR-107 is overexpressed in pituitary adenomas and inhibits the expression of aryl hydrocarbon receptor-interacting protein in vitro. Am J Physiol Endocrinol Metab 303(6):E708–E719. doi:10.1152/ajpendo.00546.2011 PubMed Trivellin G, Butz H, Delhove J, Igreja S, Chahal HS, Zivkovic V, McKay T, Patocs A, Grossman AB, Korbonits M (2012) MicroRNA miR-107 is overexpressed in pituitary adenomas and inhibits the expression of aryl hydrocarbon receptor-interacting protein in vitro. Am J Physiol Endocrinol Metab 303(6):E708–E719. doi:10.​1152/​ajpendo.​00546.​2011 PubMed
86.
Zurück zum Zitat Leontiou CA, Gueorguiev M, van der Spuy J, Quinton R, Lolli F, Hassan S, Chahal HS, Igreja SC, Jordan S, Rowe J, Stolbrink M, Christian HC, Wray J, Bishop-Bailey D, Berney DM, Wass JA, Popovic V, Ribeiro-Oliveira A Jr, Gadelha MR, Monson JP, Akker SA, Davis JR, Clayton RN, Yoshimoto K, Iwata T, Matsuno A, Eguchi K, Musat M, Flanagan D, Peters G, Bolger GB, Chapple JP, Frohman LA, Grossman AB, Korbonits M (2008) The role of the aryl hydrocarbon receptor-interacting protein gene in familial and sporadic pituitary adenomas. J Clin Endocrinol Metab 93(6):2390–2401. doi:10.1210/jc.2007-2611 PubMed Leontiou CA, Gueorguiev M, van der Spuy J, Quinton R, Lolli F, Hassan S, Chahal HS, Igreja SC, Jordan S, Rowe J, Stolbrink M, Christian HC, Wray J, Bishop-Bailey D, Berney DM, Wass JA, Popovic V, Ribeiro-Oliveira A Jr, Gadelha MR, Monson JP, Akker SA, Davis JR, Clayton RN, Yoshimoto K, Iwata T, Matsuno A, Eguchi K, Musat M, Flanagan D, Peters G, Bolger GB, Chapple JP, Frohman LA, Grossman AB, Korbonits M (2008) The role of the aryl hydrocarbon receptor-interacting protein gene in familial and sporadic pituitary adenomas. J Clin Endocrinol Metab 93(6):2390–2401. doi:10.​1210/​jc.​2007-2611 PubMed
87.
Zurück zum Zitat Beckers A, Daly AF (2007) The clinical, pathological, and genetic features of familial isolated pituitary adenomas. Eur J Endocrinol 157(4):371–382. doi:10.1530/EJE-07-0348 PubMed Beckers A, Daly AF (2007) The clinical, pathological, and genetic features of familial isolated pituitary adenomas. Eur J Endocrinol 157(4):371–382. doi:10.​1530/​EJE-07-0348 PubMed
88.
Zurück zum Zitat Moy J, Lawson D (1992) Temporal effects of estradiol and diethylstilbestrol on pituitary and plasma prolactin levels in ovariectomized Fischer 344 and Holtzman rats: a comparison of radioimmunoassay and Nb2 lymphoma cell bioassay. Proc Soc Exp Biol Med 200(4):507–513PubMed Moy J, Lawson D (1992) Temporal effects of estradiol and diethylstilbestrol on pituitary and plasma prolactin levels in ovariectomized Fischer 344 and Holtzman rats: a comparison of radioimmunoassay and Nb2 lymphoma cell bioassay. Proc Soc Exp Biol Med 200(4):507–513PubMed
89.
Zurück zum Zitat Holtzman S, Stone JP, Shellabarger CJ (1979) Influence of diethylstilbestrol treatment on prolactin cells of female ACI and Sprague–Dawley rats. Cancer Res 39(3):779–784PubMed Holtzman S, Stone JP, Shellabarger CJ (1979) Influence of diethylstilbestrol treatment on prolactin cells of female ACI and Sprague–Dawley rats. Cancer Res 39(3):779–784PubMed
90.
Zurück zum Zitat Wildi-Runge S, Bahubeshi A, Carret A, Crevier L, Robitaille Y (2011) New phenotype in the familial DICER1 tumor syndrome: pituitary blastoma presenting at age 9 months. Endocr Rev 32(03):P1–P777 Wildi-Runge S, Bahubeshi A, Carret A, Crevier L, Robitaille Y (2011) New phenotype in the familial DICER1 tumor syndrome: pituitary blastoma presenting at age 9 months. Endocr Rev 32(03):P1–P777
91.
Zurück zum Zitat Denes J, Swords FM, Xekouki P, Kumar AV, Maher ER, Ferscht N, Grieve J, Baldeweg SE, Stratakis CA, Korbonits M (2012) Familial pituitary adenoma and paraganglioma syndrome—a novel type of multiple endocrine neoplasia. Endocr Rev 33(04):OR41–OR42 Denes J, Swords FM, Xekouki P, Kumar AV, Maher ER, Ferscht N, Grieve J, Baldeweg SE, Stratakis CA, Korbonits M (2012) Familial pituitary adenoma and paraganglioma syndrome—a novel type of multiple endocrine neoplasia. Endocr Rev 33(04):OR41–OR42
92.
Zurück zum Zitat Xekouki P, Pacak K, Almeida M, Wassif CA, Rustin P, Nesterova M, de la Luz SM, Matro J, Ball E, Azevedo M, Horvath A, Lyssikatos C, Quezado M, Patronas N, Ferrando B, Pasini B, Lytras A, Tolis G, Stratakis CA (2012) Succinate dehydrogenase (SDH) D subunit (SDHD) inactivation in a growth-hormone-producing pituitary tumor: a new association for SDH? J Clin Endocrinol Metab 97(3):E357–E366. doi:10.1210/jc.2011-1179 PubMedCentralPubMed Xekouki P, Pacak K, Almeida M, Wassif CA, Rustin P, Nesterova M, de la Luz SM, Matro J, Ball E, Azevedo M, Horvath A, Lyssikatos C, Quezado M, Patronas N, Ferrando B, Pasini B, Lytras A, Tolis G, Stratakis CA (2012) Succinate dehydrogenase (SDH) D subunit (SDHD) inactivation in a growth-hormone-producing pituitary tumor: a new association for SDH? J Clin Endocrinol Metab 97(3):E357–E366. doi:10.​1210/​jc.​2011-1179 PubMedCentralPubMed
94.
Zurück zum Zitat Brahma A, Heyburn P, Swords F (2009) Familial prolactinoma occurring in association with SDHB mutation positive paraganglioma. Endocrine 19:239 Brahma A, Heyburn P, Swords F (2009) Familial prolactinoma occurring in association with SDHB mutation positive paraganglioma. Endocrine 19:239
95.
Zurück zum Zitat Coire CI, Smyth HS, Rosso D, Horvath E, Kovacs K (2010) A double pituitary adenoma presenting as a prolactin-secreting tumor with partial response to medical therapy: case report. Endocr Pathol 21(2):135–138. doi:10.1007/s12022-009-9104-0 PubMed Coire CI, Smyth HS, Rosso D, Horvath E, Kovacs K (2010) A double pituitary adenoma presenting as a prolactin-secreting tumor with partial response to medical therapy: case report. Endocr Pathol 21(2):135–138. doi:10.​1007/​s12022-009-9104-0 PubMed
96.
Zurück zum Zitat Kurozumi K, Tabuchi A, Ono Y, Tamiya T, Ohmoto T, Furuta T, Hamasaki S (2002) Pituitary adenoma associated with neurofibromatosis type 1: case report. Neurol Surg 30(7):741–745 Kurozumi K, Tabuchi A, Ono Y, Tamiya T, Ohmoto T, Furuta T, Hamasaki S (2002) Pituitary adenoma associated with neurofibromatosis type 1: case report. Neurol Surg 30(7):741–745
97.
Zurück zum Zitat Drimmie FM, MacLennan AC, Nicoll JA, Simpson E, McNeill E, Donaldson MD (2000) Gigantism due to growth hormone excess in a boy with optic glioma. Clin Endocrinol (Oxf) 53(4):535–538 Drimmie FM, MacLennan AC, Nicoll JA, Simpson E, McNeill E, Donaldson MD (2000) Gigantism due to growth hormone excess in a boy with optic glioma. Clin Endocrinol (Oxf) 53(4):535–538
98.
Zurück zum Zitat Barberis M, Gambacorta M, Versari P, Filizzolo F (1979) About a case of Recklinghausen’s disease associated with pituitary adenoma (author’s transl). Pathologica 71(1012):265–272PubMed Barberis M, Gambacorta M, Versari P, Filizzolo F (1979) About a case of Recklinghausen’s disease associated with pituitary adenoma (author’s transl). Pathologica 71(1012):265–272PubMed
99.
Zurück zum Zitat Boudin G, Pepin B, Vernant CL (1970) Multiple tumours of the nervous system in Recklinghausen’s disease. An anatomo-clinical case with chromophobe adenoma of the pituitary gland. Presse Med 78(32):1427–1430PubMed Boudin G, Pepin B, Vernant CL (1970) Multiple tumours of the nervous system in Recklinghausen’s disease. An anatomo-clinical case with chromophobe adenoma of the pituitary gland. Presse Med 78(32):1427–1430PubMed
100.
Zurück zum Zitat Hartemann P, Schmitt J, Arnould G, Kissel P (1964) Acromegaly and Recklinghausen’s neuro-fibromatosis. Apropos of 10 cases. Ann Endocrinol 25:601–618 Hartemann P, Schmitt J, Arnould G, Kissel P (1964) Acromegaly and Recklinghausen’s neuro-fibromatosis. Apropos of 10 cases. Ann Endocrinol 25:601–618
103.
Zurück zum Zitat Lips CJ, Vasen HF, Lamers CB (1984) Multiple endocrine neoplasia syndromes. Crit Rev Oncol Hematol 2(2):117–184PubMed Lips CJ, Vasen HF, Lamers CB (1984) Multiple endocrine neoplasia syndromes. Crit Rev Oncol Hematol 2(2):117–184PubMed
104.
Zurück zum Zitat Pellegata NS, Quintanilla-Martinez L, Siggelkow H, Samson E, Bink K, Hofler H, Fend F, Graw J, Atkinson MJ (2006) Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans. Proc Natl Acad Sci USA 103(42):15558–15563. doi:10.1073/pnas.0603877103 PubMedCentralPubMed Pellegata NS, Quintanilla-Martinez L, Siggelkow H, Samson E, Bink K, Hofler H, Fend F, Graw J, Atkinson MJ (2006) Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans. Proc Natl Acad Sci USA 103(42):15558–15563. doi:10.​1073/​pnas.​0603877103 PubMedCentralPubMed
105.
106.
Zurück zum Zitat Daly AF, Jaffrain-Rea ML, Ciccarelli A, Valdes-Socin H, Rohmer V, Tamburrano G, Borson-Chazot C, Estour B, Ciccarelli E, Brue T, Ferolla P, Emy P, Colao A, de Menis E, Lecomte P, Penfornis F, Delemer B, Bertherat J, Wemeau JL, De Herder W, Archambeaud F, Stevenaert A, Calender A, Murat A, Cavagnini F, Beckers A (2006) Clinical characterization of familial isolated pituitary adenomas. J Clin Endocr Metab 91(9):3316–3323. doi:10.1210/jc.2005-2671 PubMed Daly AF, Jaffrain-Rea ML, Ciccarelli A, Valdes-Socin H, Rohmer V, Tamburrano G, Borson-Chazot C, Estour B, Ciccarelli E, Brue T, Ferolla P, Emy P, Colao A, de Menis E, Lecomte P, Penfornis F, Delemer B, Bertherat J, Wemeau JL, De Herder W, Archambeaud F, Stevenaert A, Calender A, Murat A, Cavagnini F, Beckers A (2006) Clinical characterization of familial isolated pituitary adenomas. J Clin Endocr Metab 91(9):3316–3323. doi:10.​1210/​jc.​2005-2671 PubMed
107.
Zurück zum Zitat Chahal HS, Chapple JP, Frohman LA, Grossman AB, Korbonits M (2010) Clinical, genetic and molecular characterization of patients with familial isolated pituitary adenomas (FIPA). Trends Endocrinol Metab 21(7):419–427. doi:10.1016/j.tem.2010.02.007 PubMed Chahal HS, Chapple JP, Frohman LA, Grossman AB, Korbonits M (2010) Clinical, genetic and molecular characterization of patients with familial isolated pituitary adenomas (FIPA). Trends Endocrinol Metab 21(7):419–427. doi:10.​1016/​j.​tem.​2010.​02.​007 PubMed
108.
Zurück zum Zitat Chahal HS, Stals K, Unterlander M, Balding DJ, Thomas MG, Kumar AV, Besser GM, Atkinson AB, Morrison PJ, Howlett TA, Levy MJ, Orme SM, Akker SA, Abel RL, Grossman AB, Burger J, Ellard S, Korbonits M (2011) AIP mutation in pituitary adenomas in the 18th century and today. N Engl J Med 364(1):43–50. doi:10.1056/NEJMoa1008020 PubMed Chahal HS, Stals K, Unterlander M, Balding DJ, Thomas MG, Kumar AV, Besser GM, Atkinson AB, Morrison PJ, Howlett TA, Levy MJ, Orme SM, Akker SA, Abel RL, Grossman AB, Burger J, Ellard S, Korbonits M (2011) AIP mutation in pituitary adenomas in the 18th century and today. N Engl J Med 364(1):43–50. doi:10.​1056/​NEJMoa1008020 PubMed
109.
Zurück zum Zitat Beckers A, Aaltonen LA, Daly AF, Karhu A (2013) Familial isolated pituitary adenomas (FIPA) and the pituitary adenoma predisposition due to mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene. Endocr Rev 34(2):239–277. doi:10.1210/er.2012-1013 PubMedCentralPubMed Beckers A, Aaltonen LA, Daly AF, Karhu A (2013) Familial isolated pituitary adenomas (FIPA) and the pituitary adenoma predisposition due to mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene. Endocr Rev 34(2):239–277. doi:10.​1210/​er.​2012-1013 PubMedCentralPubMed
110.
Zurück zum Zitat Stratakis CA, Horvath A (1993) Carney complex. GeneReviews, Seattle Stratakis CA, Horvath A (1993) Carney complex. GeneReviews, Seattle
111.
Zurück zum Zitat Asa SL, Kovacs K, Stefaneanu L, Horvath E, Billestrup N, Gonzalez-Manchon C, Vale W (1992) Pituitary adenomas in mice transgenic for growth hormone-releasing hormone. Endocrinology 131(5):2083–2089PubMed Asa SL, Kovacs K, Stefaneanu L, Horvath E, Billestrup N, Gonzalez-Manchon C, Vale W (1992) Pituitary adenomas in mice transgenic for growth hormone-releasing hormone. Endocrinology 131(5):2083–2089PubMed
112.
Zurück zum Zitat Mayo KE, Hammer RE, Swanson LW, Brinster RL, Rosenfeld MG, Evans RM (1988) Dramatic pituitary hyperplasia in transgenic mice expressing a human growth hormone-releasing factor gene. Mol Endocrinol 2(7):606–612PubMed Mayo KE, Hammer RE, Swanson LW, Brinster RL, Rosenfeld MG, Evans RM (1988) Dramatic pituitary hyperplasia in transgenic mice expressing a human growth hormone-releasing factor gene. Mol Endocrinol 2(7):606–612PubMed
113.
Zurück zum Zitat Sano T, Asa SL, Kovacs K (1988) Growth hormone-releasing hormone-producing tumors: clinical, biochemical, and morphological manifestations. Endocr Rev 9(3):357–373. doi:10.1210/edrv-9-3-357 PubMed Sano T, Asa SL, Kovacs K (1988) Growth hormone-releasing hormone-producing tumors: clinical, biochemical, and morphological manifestations. Endocr Rev 9(3):357–373. doi:10.​1210/​edrv-9-3-357 PubMed
114.
Zurück zum Zitat Thorner MO, Perryman RL, Cronin MJ, Rogol AD, Draznin M, Johanson A, Vale W, Horvath E, Kovacs K (1982) Somatotroph hyperplasia. Successful treatment of acromegaly by removal of a pancreatic islet tumor secreting a growth hormone-releasing factor. J Clin Invest 70(5):965–977PubMedCentralPubMed Thorner MO, Perryman RL, Cronin MJ, Rogol AD, Draznin M, Johanson A, Vale W, Horvath E, Kovacs K (1982) Somatotroph hyperplasia. Successful treatment of acromegaly by removal of a pancreatic islet tumor secreting a growth hormone-releasing factor. J Clin Invest 70(5):965–977PubMedCentralPubMed
115.
Zurück zum Zitat Sugiyama K, Kimura M, Abe T, Ikezawa Y, Manaka H, Yamatani K, Tominaga M, Sasaki H, Misawa T (1996) Hyper-adrenocorticotropinemia in a patient with Addison’s disease after treatment with corticosteroids. Intern Med 35(7):555–559PubMed Sugiyama K, Kimura M, Abe T, Ikezawa Y, Manaka H, Yamatani K, Tominaga M, Sasaki H, Misawa T (1996) Hyper-adrenocorticotropinemia in a patient with Addison’s disease after treatment with corticosteroids. Intern Med 35(7):555–559PubMed
117.
Zurück zum Zitat Gorbman A (1950) Functional and structural changes consequent to high dosages of radioactive iodine. J Clin Endocrinol Metab 10(10):1177–1191PubMed Gorbman A (1950) Functional and structural changes consequent to high dosages of radioactive iodine. J Clin Endocrinol Metab 10(10):1177–1191PubMed
118.
Zurück zum Zitat Ueno M, Inano H, Onoda M, Murase H, Ikota N, Kagiya TV, Anzai K (2009) Modification of mortality and tumorigenesis by tocopherol-mono-glucoside (TMG) administered after X irradiation in mice and rats. Radiat Res 172(4):519–524. doi:10.1667/RR1695.1 PubMed Ueno M, Inano H, Onoda M, Murase H, Ikota N, Kagiya TV, Anzai K (2009) Modification of mortality and tumorigenesis by tocopherol-mono-glucoside (TMG) administered after X irradiation in mice and rats. Radiat Res 172(4):519–524. doi:10.​1667/​RR1695.​1 PubMed
119.
Zurück zum Zitat Johnson KA, Gorzinski SJ, Bodner KM, Campbell RA, Wolf CH, Friedman MA, Mast RW (1986) Chronic toxicity and oncogenicity study on acrylamide incorporated in the drinking water of Fischer 344 rats. Toxicol Appl Pharmacol 85(2):154–168. doi:10.1016/0041-008X(86)90109-2 PubMed Johnson KA, Gorzinski SJ, Bodner KM, Campbell RA, Wolf CH, Friedman MA, Mast RW (1986) Chronic toxicity and oncogenicity study on acrylamide incorporated in the drinking water of Fischer 344 rats. Toxicol Appl Pharmacol 85(2):154–168. doi:10.​1016/​0041-008X(86)90109-2 PubMed
121.
Zurück zum Zitat Cannavo S, Ferrau F, Ragonese M, Curto L, Torre ML, Magistri M, Marchese A, Alibrandi A, Trimarchi F (2010) Increased prevalence of acromegaly in a highly polluted area. Eur J Endocrinol 163(4):509–513. doi:10.1530/EJE-10-0465 PubMed Cannavo S, Ferrau F, Ragonese M, Curto L, Torre ML, Magistri M, Marchese A, Alibrandi A, Trimarchi F (2010) Increased prevalence of acromegaly in a highly polluted area. Eur J Endocrinol 163(4):509–513. doi:10.​1530/​EJE-10-0465 PubMed
122.
Zurück zum Zitat Pesatori AC, Baccarelli A, Consonni D, Lania A, Beck-Peccoz P, Bertazzi PA, Spada A (2008) Aryl hydrocarbon receptor-interacting protein and pituitary adenomas: a population-based study on subjects exposed to dioxin after the Seveso, Italy, accident. Eur J Endocrinol 159(6):699–703. doi:10.1530/EJE-08-0593 PubMed Pesatori AC, Baccarelli A, Consonni D, Lania A, Beck-Peccoz P, Bertazzi PA, Spada A (2008) Aryl hydrocarbon receptor-interacting protein and pituitary adenomas: a population-based study on subjects exposed to dioxin after the Seveso, Italy, accident. Eur J Endocrinol 159(6):699–703. doi:10.​1530/​EJE-08-0593 PubMed
Metadaten
Titel
Epidemiology and etiopathogenesis of pituitary adenomas
verfasst von
Elena D. Aflorei
Márta Korbonits
Publikationsdatum
01.05.2014
Verlag
Springer US
Erschienen in
Journal of Neuro-Oncology / Ausgabe 3/2014
Print ISSN: 0167-594X
Elektronische ISSN: 1573-7373
DOI
https://doi.org/10.1007/s11060-013-1354-5

Weitere Artikel der Ausgabe 3/2014

Journal of Neuro-Oncology 3/2014 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.